Evaluation of immune responses to Brucella vaccines in mouse models: A systematic review

IntroductionDespite the accessibility of several live attenuated vaccines for animals, currently, there is no licensed vaccine for brucellosis in human populations. Available and confirmed animal vaccines may be harmful and considered inappropriate for humans. Thus, human vaccines for brucellosis ar...

Full description

Bibliographic Details
Main Authors: Atieh Darbandi, Shabnam Zeighamy Alamdary, Maryam Koupaei, Roya Ghanavati, Mohsen Heidary, Malihe Talebi
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-09-01
Series:Frontiers in Veterinary Science
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fvets.2022.903890/full
_version_ 1817992390571458560
author Atieh Darbandi
Shabnam Zeighamy Alamdary
Maryam Koupaei
Roya Ghanavati
Mohsen Heidary
Mohsen Heidary
Malihe Talebi
author_facet Atieh Darbandi
Shabnam Zeighamy Alamdary
Maryam Koupaei
Roya Ghanavati
Mohsen Heidary
Mohsen Heidary
Malihe Talebi
author_sort Atieh Darbandi
collection DOAJ
description IntroductionDespite the accessibility of several live attenuated vaccines for animals, currently, there is no licensed vaccine for brucellosis in human populations. Available and confirmed animal vaccines may be harmful and considered inappropriate for humans. Thus, human vaccines for brucellosis are required. We aimed to evaluate the effects of Brucella vaccines on mouse models and discuss the potential mechanisms of these vaccines for the design of the appropriate human vaccines.Materials and methodsA systematic search was carried out in Web of Science, Embase, and PubMed/Medline databases. The following MeSH terms were applied: brucellosis, vaccine, Brucella, and vaccination. The original manuscripts describing the Brucella vaccines on mouse models were included. The review articles, editorials, correspondences, case reports, case series, duplicate publications, and articles with insufficient data were excluded.ResultsOf the 163 full texts that were screened, 17 articles reached to inclusion criteria. Combining the results of these trials revealed a reduction in bacterial load and colonization rate of Brucella in the spleen, an increase in inflammatory markers, especially IFN-γ and IL-4, and the highest levels of antibody classes in vaccinated animals compared to animals challenged with various virulent strains of Brucella. The majority of studies found that different anti-Brucella vaccines induced a significant protective effect in animals challenged with Brucella strains. Additionally, mice were given the highest level of Brucella vaccine protection and significant clearance of Brucella strains when the immunization was delivered via the IP (intraperitoneal) or IP-IN (intranasal) routes.ConclusionBrucella is responsible for half-million new cases globally annually, and the lack of a proper human vaccine poses the risk of brucellosis. A variety of vaccines are used to prevent brucellosis. Subunit vaccines and recombinant human vaccines have higher safety and protective properties. Although vaccination helps brucellosis control, it does not eradicate the disease. Thus, we recommend the following strategies. (a) establishment of a registration system; (b) close monitoring of slaughterhouses, markets, and herds; (c) training veterinarians; (d) legal protection of the consequences of non-compliance with preventive measures.
first_indexed 2024-04-14T01:26:34Z
format Article
id doaj.art-a9395e2f75c9472c982c7535ab92e6f3
institution Directory Open Access Journal
issn 2297-1769
language English
last_indexed 2024-04-14T01:26:34Z
publishDate 2022-09-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Veterinary Science
spelling doaj.art-a9395e2f75c9472c982c7535ab92e6f32022-12-22T02:20:26ZengFrontiers Media S.A.Frontiers in Veterinary Science2297-17692022-09-01910.3389/fvets.2022.903890903890Evaluation of immune responses to Brucella vaccines in mouse models: A systematic reviewAtieh Darbandi0Shabnam Zeighamy Alamdary1Maryam Koupaei2Roya Ghanavati3Mohsen Heidary4Mohsen Heidary5Malihe Talebi6Department of Microbiology, School of Medicine, Iran University of Medical Sciences, Tehran, IranDepartment of Bacteriology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, IranDepartment of Microbiology and Immunology, School of Medicine, Kashan University of Medical Sciences, Kashan, IranBehbahan Faculty of Medical Sciences, Behbahan, IranDepartment of Laboratory Sciences, School of Paramedical Sciences, Sabzevar University of Medical Sciences, Sabzevar, IranCellular and Molecular Research Center, Sabzevar University of Medical Sciences, Sabzevar, IranDepartment of Microbiology, School of Medicine, Iran University of Medical Sciences, Tehran, IranIntroductionDespite the accessibility of several live attenuated vaccines for animals, currently, there is no licensed vaccine for brucellosis in human populations. Available and confirmed animal vaccines may be harmful and considered inappropriate for humans. Thus, human vaccines for brucellosis are required. We aimed to evaluate the effects of Brucella vaccines on mouse models and discuss the potential mechanisms of these vaccines for the design of the appropriate human vaccines.Materials and methodsA systematic search was carried out in Web of Science, Embase, and PubMed/Medline databases. The following MeSH terms were applied: brucellosis, vaccine, Brucella, and vaccination. The original manuscripts describing the Brucella vaccines on mouse models were included. The review articles, editorials, correspondences, case reports, case series, duplicate publications, and articles with insufficient data were excluded.ResultsOf the 163 full texts that were screened, 17 articles reached to inclusion criteria. Combining the results of these trials revealed a reduction in bacterial load and colonization rate of Brucella in the spleen, an increase in inflammatory markers, especially IFN-γ and IL-4, and the highest levels of antibody classes in vaccinated animals compared to animals challenged with various virulent strains of Brucella. The majority of studies found that different anti-Brucella vaccines induced a significant protective effect in animals challenged with Brucella strains. Additionally, mice were given the highest level of Brucella vaccine protection and significant clearance of Brucella strains when the immunization was delivered via the IP (intraperitoneal) or IP-IN (intranasal) routes.ConclusionBrucella is responsible for half-million new cases globally annually, and the lack of a proper human vaccine poses the risk of brucellosis. A variety of vaccines are used to prevent brucellosis. Subunit vaccines and recombinant human vaccines have higher safety and protective properties. Although vaccination helps brucellosis control, it does not eradicate the disease. Thus, we recommend the following strategies. (a) establishment of a registration system; (b) close monitoring of slaughterhouses, markets, and herds; (c) training veterinarians; (d) legal protection of the consequences of non-compliance with preventive measures.https://www.frontiersin.org/articles/10.3389/fvets.2022.903890/fullbrucellosisvaccineBrucellavaccinationmouse
spellingShingle Atieh Darbandi
Shabnam Zeighamy Alamdary
Maryam Koupaei
Roya Ghanavati
Mohsen Heidary
Mohsen Heidary
Malihe Talebi
Evaluation of immune responses to Brucella vaccines in mouse models: A systematic review
Frontiers in Veterinary Science
brucellosis
vaccine
Brucella
vaccination
mouse
title Evaluation of immune responses to Brucella vaccines in mouse models: A systematic review
title_full Evaluation of immune responses to Brucella vaccines in mouse models: A systematic review
title_fullStr Evaluation of immune responses to Brucella vaccines in mouse models: A systematic review
title_full_unstemmed Evaluation of immune responses to Brucella vaccines in mouse models: A systematic review
title_short Evaluation of immune responses to Brucella vaccines in mouse models: A systematic review
title_sort evaluation of immune responses to brucella vaccines in mouse models a systematic review
topic brucellosis
vaccine
Brucella
vaccination
mouse
url https://www.frontiersin.org/articles/10.3389/fvets.2022.903890/full
work_keys_str_mv AT atiehdarbandi evaluationofimmuneresponsestobrucellavaccinesinmousemodelsasystematicreview
AT shabnamzeighamyalamdary evaluationofimmuneresponsestobrucellavaccinesinmousemodelsasystematicreview
AT maryamkoupaei evaluationofimmuneresponsestobrucellavaccinesinmousemodelsasystematicreview
AT royaghanavati evaluationofimmuneresponsestobrucellavaccinesinmousemodelsasystematicreview
AT mohsenheidary evaluationofimmuneresponsestobrucellavaccinesinmousemodelsasystematicreview
AT mohsenheidary evaluationofimmuneresponsestobrucellavaccinesinmousemodelsasystematicreview
AT malihetalebi evaluationofimmuneresponsestobrucellavaccinesinmousemodelsasystematicreview